Apnimed has announced The Lancet has published positive results from the Phase 2 FLOW study evaluating sulthiame, a differentiated, once-daily oral carbonic anhydrase inhibitor, in the treatment of ...

Apnimed, Inc., a pharmaceutical company building the industry-leading portfolio of first-in-class oral drug candidates that address the root causes of obstructive sleep apnea (OSA) and other ...

A research team led by the University of Cambridge is rethinking how this crucial industry runs, aiming to “de-fossilize” it ...

Cambridge researchers have engineered a solar-powered “artificial leaf” that mimics photosynthesis to make valuable chemicals ...

Cambridge scientists have built a solar-powered leaf that turns carbon dioxide into sustainable fuel and everyday chemicals.

Detailed price information for Medpace Holdings Inc (MEDP-Q) from The Globe and Mail including charting and trades.

The collaboration between the University and CyanoCapture will focus on developing innovative methods for producing targeted delivery systems using engineered carboxysomes, combining advanced ...

Cambridge researchers create solar-powered artificial leaf to cut emissions from the chemical industry. Read more.

THE classical theory of the mechanism of production of the carbonate fraction of the calcium carbonate of the hen's egg shell is that of Gutowska and Mitchell 1. This theory makes use of the enzyme ...

The University of Liverpool rand CyanoCapture Ltd are joining forces to develop the next generation of carboxysome-based ...

Amy is a health reporter and writer with extensive experience covering health conditions, fitness, mental health, and nutrition. She also writes about outdoors and travel. In addition to Health, her ...